Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignancies.
Biber G, Ben-Shmuel A, Noy E, Joseph N, Puthenveetil A, Reiss N, Levy O, Lazar I, Feiglin A, Ofran Y, Kedmi M, Avigdor A, Fried S, Barda-Saad M.
Biber G, et al. Among authors: feiglin a.
Nat Commun. 2021 Sep 22;12(1):5581. doi: 10.1038/s41467-021-25842-7.
Nat Commun. 2021.
PMID: 34552085
Free PMC article.